Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United Kingdom

Environmental Health Perspectives

Volumn 113, Issue 12, 2005, Pages 1705-1711

  Bound, Jonathan P ^a   Voulvoulis, Nikolaos ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Drugs; Prescriptions; Risk assessment; Survey; Wastewater treatment

Indexed keywords

AMOXICILLIN; ATENOLOL; ATORVASTATIN; BEZAFIBRATE; CARBAMAZEPINE; CETIRIZINE; CONTRACEPTIVE AGENT; DICLOFENAC; ERYTHROMYCIN; ETHINYLESTRADIOL; FELBAMATE; FLUOXETINE; GEMFIBROZIL; IBUPROFEN; INDOMETACIN; KETOPROFEN; LORATADINE; METOPROLOL; NAPROXEN; PARACETAMOL; PENICILLIN DERIVATIVE; PROPRANOLOL; RISPERIDONE; SULFAMETHOXAZOLE;

ARTICLE; BIOLOGICAL MODEL; ENVIRONMENTAL IMPACT; HEALTH HAZARD; HEALTH SURVEY; INTERVIEW; MARINE ENVIRONMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SEWAGE TREATMENT; TOXICITY; UNITED KINGDOM; WASTE DISPOSAL; WASTE WATER MANAGEMENT; WATER CONTAMINATION;

GREAT BRITAIN; INTERVIEWS; MODELS, THEORETICAL; PHARMACEUTICAL PREPARATIONS; REFUSE DISPOSAL; WATER POLLUTANTS, CHEMICAL;

EID: 29144502284     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.8315     Document Type: Article

References (74)

1. Ahel M, Mikac N, Cosovic B, Prohic E, Soukup V. 1998. The impact of contamination from a municipal solid waste landfill (Zagreb, Croatia) on underlying soil. Water Sci Technol 37:203-210.
2. Altenburger R, Walter H, Grote M. 2004. What contributes to the combined effect of a complex mixture? Environ Sci Technol 38:6353-6362.
3. Andreozzi R, Marotta R, Pinto G, Pollio A. 2002. Carbamazepine in water: persistence in the environment, ozonation treatment and preliminary assessment on algal toxicity. Water Res 36:2869-2877.
4. Arcand-Hoy LD, Nimrod AC, Benson WH. 1998. Endocrine modulating substances in the environment: estrogenic effects of pharmaceutical products. Int J Toxicol 17:139-158.
5. Berger K, Petersen B, Buening-Pfaue H. 1986. Persistence of drugs occurring in liquid manure in the food chain [in German]. Arch Für Lebensmittelhyg 37:99-102.
6. Boehringer SK. 2004. What's the best way to dispose of medications? Pharm Lett 20. Available: http://www.epa.gov/esd/chemistry/ppcp/images/pharmacist.pdf [accessed 18 October 2005].
7. Bound JP, Kitsou K, Voulvoulis N. In press. Household disposal of pharmaceuticals and perception of risk to the environment. Environ Toxicol Pharmacol.
8. Bound JP, Voulvoulis N. 2004. Pharmaceuticals in the aquatic environment - a comparison of risk assessment strategies. Chemosphere 56:1143-1155.
9. Braybrook S, John DN, Leong K. 1999. A survey of why medicines are returned to pharmacies. Pharm J 263:R30.
10. Brooks BW, Foran CM, Richards SM, Weston J, Turner PK, Stanley JK, et al. 2003. Aquatic ecotoxicology of fluoxetine. Toxicol Lett 142:169-183.
11. Buser HR, Muller MD, Theobald N. 1998. Occurrence of the pharmaceutical drug clofibric acid and the herbicide mecoprop in various Swiss lakes and in the North Sea. Environ Sci Technol 32:188-192.
12. Buser HR, Poiger T, Muller MD. 1999. Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ Sci Technol 33:2529-2535.
13. Calamari D, Zuccato E, Castiglioni S, Bagnati R, Fanelli R. 2003. Strategic survey of therapeutic drugs in the rivers Po and Lambro in northern Italy. Environ Sci Technol 37:1241-1248.
14. Carballa M, Omil F, Lema JM, Llompart M, Garcia-Jares C, Rodriguez I, et al. 2004. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res 38:2918-2926.
15. Cleuvers M. 2004. Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicol Environ Saf 59:309-315.
16. COMPAS Inc. 2002. F&DA Environmental Assessment Regulations Project Benchmark Survey: A Report to Health Canada (POR-02-13). Available: http://www.hc-sc.gc.ca/ewh-semt/alt_formats/hpfb-dgpsa/pdf/ contaminants/rep-rap_por-02-03_e.pdf
17. Daughton CG. 2003a. Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. Rationale for and avenues toward a green pharmacy. Environ Health Perspect 111:757-774.
18. Daughton CG. 2003b. Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. II. Drug disposal, waste reduction, and future directions. Environ Health Perspect 111:775-785.
19. Daughton CG, Ternes TA. 1999. Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect 107:907-942.
20. Diaz-Cruz MS, Lopez de Alda MJ, Barcelo D. 2003. Environmental behavior and analysis of veterinary and human drugs in soils, sediments and sludge. Trends Anal Chem 22:340-351.
21. Dollery C, ed. 1991. Therapeutic Drugs. Edinburgh:Churchill Livingstone.
22. Donovan JL, Blake DR. 1992. Patient noncompliance - deviance or reasoned decision-making. Soc Sci Med 34:507-513.
23. Eckel WP, Ross B, Isensee RK. 1993. Pentobarbitol found in groundwater. Groundwater 31:801-804.
24. EMEA. 2001. Discussion Paper on Environmental Risk Assessment of Non-genetically Modified Organisms (Non-GMO) Containing Medicinal Products for Human Use. Report no. CPMP/SWP/4447/00 draft. London:European Agency for the Evaluation of Medicinal Products.
25. EMEA. 2005. Guidance on Environmental Risk Assessment of Medicinal Products for Human Use. CPMP/SWP/4447/00 draft. London:European Agency for the Evaluation of Medicinal Products. Available: http://www.emea.eu.int/pdfs/human/swp/444700en.pdf [accessed 20 October 2005].
26. Evans C, Crawford B. 1999. Patient self reports in pharmacoeconomic studies. Pharmacoeconomics 15:241-256.
27. FDA. 1998. Guidance for Industry - Environmental Assessment of Human Drugs and Biologics Applications. CDER/CBER, CMC 6, rev 1. Rockville, MD:Food and Drug Administration.
28. Halling-Sorensen B, Nors-Nielsen SN, Lanzky PF, Ingerslev F, Holten Lutzhoft HC, Jorgensen SE. 1998. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 36:357-393.
29. Heberer T. 2002. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett 131:5-17.
30. Heberer T, Dunnbier U, Reilich C, Stan HJ. 1997. Detection of drugs and drug metabolites in ground water samples of a drinking water treatment plant. Fresenius Environ Bull 6:438-443.
31. Hirsch R, Ternes T, Haberer K, Kratz KL. 1999. Occurrence of antibiotics in the aquatic environment. Sci Total Environ 225:109-118.
32. HMSO. 1992. The Controlled Waste Regulations 1992. London:Her Majesty's Stationery Office. Available: http://www.hmso.gov.uk/si/si1992/Uksi_19920588_en_1.htm [accessed 20 October 2005].
33. HMSO. 1996. The Special Waste Regulations 1996. London:Her Majesty's Stationery Office. Available: http://www.hmso.gov.uk/si/si1996/Uksi_19960972_en_1.htm [accessed 20 October 2005].
34. Holm JV, Rugge K, Bjerg PL, Christensen TH. 1995. Occurrence and distribution of pharmaceutical compounds in the groundwater downgradient of a landfill (Grinstead, Denmark). Environ Sci Technol 29:1415-1420.
35. Huschek G, Hansen PD, Maurer HH, Krengel D, Kayser A. 2004. Environmental risk assessment of medicinal products for human use according to European commission recommendations. Environ Toxicol 19:226-240.
36. Jjemba PK. 2002. The potential impact of veterinary and human therapeutic agents in manure and biosolids on plants grown on arable land: a review. Agric Ecosyst Environ 93:267-278.
37. Jjemba PK. In press. Excretion and ecotoxicity of pharmaceutical and personal care products in the environment. Ecotoxicol Environ Saf.
38. Jobling S, Nolan M, Tyler CR, Brighty G, Sumpter JP. 1998. Widespread sexual disruption in wild fish. Environ Sci Technol 32:2498.
39. Jones OAH, Voulvoulis N, Lester JN. 2001. Human pharmaceuticals in the aquatic environment: a review. Environ Technol 22:1383-1394.
40. Jones OAH, Voulvoulis N, Lester JN. 2002. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res 36:5013-5022.
41. Jones OAH, Voulvoulis N, Lester JN. 2003. Potential impact of pharmaceuticals on environmental health. Bull WHO 81:768-769.
42. Kanda R, Griffin P, James HA, Fothergill J. 2003. Pharmaceutical and personal care products in sewage treatment works. J Environ Monit 5:823-830.
43. Kolpin DW, Furlong ET, Meyer M, Thurman EM, Zaugg SD, Barber LB, et al. 2002. Pharmaceuticals, hormones and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ Sci Technol 36:1202-1211.
44. Kreuzinger N, Clara M, Strenn B, Vogel B. 2004. Investigation on the behaviour of selected pharmaceuticals in the groundwater after infiltration of treated wastewater. Water Sci Technol 50:221-228.
45. Kuspis DA, Krenzelok EP. 1996. What happens to expired medications? A survey of community medication disposal. Vet Human Toxicol 38:48-49.
46. Länge R, Hutchinson TH, Croudace CP, Siegmund F. 2001. Effects of the synthetic estrogen 17 alpha-ethinylestradiol on the life-cycle of the fathead minnow (Pimephales promelas). Environ Toxicol Chem 20:1216.
47. Lee RB, Sarafin K, Peart TE, Svoboda ML. 2003. Acidic pharmaceuticals in sewage - methodology, stability test, occurrence, and removal from Ontario samples. Water Qual Res J Canada 38:667-682.
48. Leff LG, Dana JR, McArthur JV, Shimkets LJ. 1993. Detection of Tn5-like sequences in kanamycin-resistant stream bacteria and environmental DNA. Appl Environ Microbiol 59:417-421.
49. Martindale W, ed. 1993. Martindale: The Extra Pharmacopoeia. 13th ed. London:Pharmaceutical Press.
50. McCall CH. 1982. Sampling and Statistics: Handbook for Research. Ames, IA:Iowa State University Press.
51. NCSL (National Conference of State Legislatures). Health Care Program: Recent Medicaid Prescription Drug Laws and Strategies, 2001-2005. Available: http://www.ncsl.org/programs/health/medicaidrx.htm [accessed 20 October 2005].
52. Petersen A, Andersen JS, Kaewmak T, Somsiri T, Dalsgaard A. 2002. Impact of integrated fish farming on antimicrobial resistance in a pond environment. Appl Environ Microbiol 68:6036-6042.
53. Peterson RA. 2000. Constructing Effective Questionnaires. Thousand Oaks, CA:Sage Publications.
54. Pray WS, Pray JJ. 2004. Childhood poisoning. What should be done? US Pharm 29:3.
55. Purdom CE, Hardiman PA, Bye VJ, Eno NC, Tyler CR, Sumpter JP. 1994. Estrogenic effects of effluents from sewage treatment works. Chem Ecol 8:275-285.
56. Richards SM, Wilson CJ, Johnson DJ, Castle DM, Lam M, Mabury SA, et al. 2004. Effects of pharmaceutical mixtures in aquatic microcosms. Environ Toxicol Chem 23:1035-1042.
57. Rodgers-Gray TP, Jobling S, Morris S, Kelly C, Kirby S, Janbakhsh A, et al. 2000. Long-term temporal changes in the estrogenic composition of treated sewage effluent and its biological effects on fish. Environ Sci Technol 34:1521-1528.
58. Rodriguez I, Quintana JB, Carpinteiro J, Carro AM, Lorenzo RA, Cela R. 2003. Determination of acidic drugs in sewage water by gas chromatography-mass spectrometry as tertbutyldimethylsilyl derivatives. J Chromatogr A 985:265-274.
59. Routledge EJ, Sheahan D, Desbrow C, Brighty GC, Waldock M, Sumpter JP. 1998. Identification of estrogenic chemicals in STW effluent. 2. In vivo responses in trout and roach. Environ Sci Technol 32:1559.
60. RxList. 2005a. Nadolol: Clinical Pharmacology. Available: http://www.rxlist.com/cgi/generic3/nadolol_cp.htm [accessed 20 October 2005].
61. RxList. 2005b. Carbamazepine: Clinical Pharmacology. Available: http://www.rxlist.com/cgi/generic/carbam_cp.htm [accessed 20 October 2005].
62. RxList. 2005c. Felbamate: Clinical Pharmacology. Available: http://www.rxlist.com/cgi/generic3/felbamate_cp.htm [accessed 20 October 2005].
63. RxList. 2005d. Cetirizine: Clinical Pharmacology. Available: http://www.rxlist.com/cgi/generic/cetiriz_cp.htm [accessed 20 October 2005].
64. Schwartz T, Kohnen W, Jansen B, Obst U. 2002. Detection of antibiotic-resistant bacteria and their resistance genes in wastewater, surface water, and drinking water biofilms. FEMS Micro Ecol 1470:1-11.
65. Schwarzbauer J, Heim S, Brinker S, Littke R. 2002. Occurrence and alteration of organic contaminants in seepage and leakage water from a waste deposit landfill. Water Res 36:2275-2287.
66. Slack RJ, Gronow J, Voulvoulis N. 2005a. Household hazardous waste in municipal landfills: contaminants in leachate. Sci Total Environ 337:119-137.
67. Slack RJ, Zerva P, Gronow JR, Voulvoulis N. 2005b. Assessing quantities and disposal routes for household hazardous products in the United Kingdom. Environ Sci Technol 39:1912-1919.
68. Stumpf M, Ternes TA, Wilken RD, Rodrigues SV, Baumann W. 1999. Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci Total Environ 225:135-141.
69. Ternes TA. 1998. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32:3245-3257.
70. Ternes TA, Stumpf M, Mueller J, Haberer K, Wilken RD, Servos M. 1999. Behavior and occurrence of estrogens in municipal sewage treatment plants - I. Investigations in Germany, Canada and Brazil. Sci Total Environ 225:81.
71. Wintgens T, Gallenkemper M, Melin T. 2003. Occurrence and removal of endocrine disrupters in landfill leachate treatment plants. Water Sci Technol 48:127-134.
72. Wollenberger L, Halling-Sorensen B, Kusk KO. 2000. Acute and chronic toxicity of veterinary antibiotics to Daphnia magna. Chemosphere 40:723-730.
73. Wu JJ, Wu CC, Ma HW, Chang CC. 2004. Treatment of landfill leachate by ozone-based advanced oxidation processes. Chemosphere 54:997-1003.
74. Xia K, Bhandari A, Das K, Pillar G. 2005. Occurrence and fate of pharmaceuticals and personal care products (PPCPs) in biosolids. J Environ Qual 34:91-104